开立医疗: 监事会决议公告

Group 1 - The fourth meeting of the supervisory board of Shenzhen Kaili Biomedical Technology Co., Ltd. was held, with all three supervisors present, meeting the legal requirements for decision-making [1] - The supervisory board unanimously approved the review of the company's 2025 semi-annual report, confirming that the report accurately reflects the company's actual situation without any false records or misleading statements [1][2] - The supervisory board also approved the special report on the storage and use of raised funds for the first half of 2025, stating that it complies with relevant regulations and does not involve any violations or changes that could harm shareholder interests [1][2] Group 2 - The voting results for both resolutions were unanimous, with 3 votes in favor and no votes against or abstaining, indicating full agreement among the supervisory board members [1][2] - The detailed reports are available on the designated information disclosure website of the China Securities Regulatory Commission [2]